Serhat Ünal
Impact in
- Infectious Diseases top 0.05%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
- Health top 0.1%
- Vaccine Coverage and Hesitancy
Papers in
-
- Antimicrobial Resistance in Staphylococcus 37
- SARS-CoV-2 and COVID-19 Research 25
- COVID-19 Clinical Research Studies 21
-
- Antibiotic Use and Resistance 31
- Co-authors
- Adi̇l Deni̇zli̇ (10 shared papers)Serap Şimşek Yavuz (1 shared paper)Ömrüm Uzun (24 shared papers)Yeşeren Saylan (2 shared papers)Murat Akova (22 shared papers)Deniz Gür (16 shared papers)Duygu Yazgan Aksoy (7 shared papers)Halis Akalın (9 shared papers)
- Journals
- International Journal of Antimicrobial Agents (19 papers)Clinical Microbiology and Infection (9 papers)Antimicrobial Agents and Chemotherapy (8 papers)Journal of Antimicrobial Chemotherapy (7 papers)Vaccines (7 papers)
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Serhat Ünal
268 papers receiving 17.4k citations
Serhat Ünal's Hit Papers
Peers
Comparison fields: 5 of 186
- Infectious Diseases 9.5k
- Health 2.0k
- Modeling and Simulation 988
- Applied Microbiology and Biotechnology 366
- Molecular Medicine 518
Countries citing papers authored by Serhat Ünal
This map shows the geographic impact of Serhat Ünal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serhat Ünal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serhat Ünal more than expected).
Fields of papers citing papers by Serhat Ünal
This network shows the impact of papers produced by Serhat Ünal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serhat Ünal. The network helps show where Serhat Ünal may publish in the future.
Co-authors
The 25 scholars most cited alongside Serhat Ünal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 286 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine Hit paper breakdown → | 2020 | 11310 |
| 2 | Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey Hit paper breakdown → | 2021 | 701 |
| 3 | 2014 | 265 | |
| 4 | 2019 | 255 | |
| 5 | 2020 | 252 | |
| 6 | 2019 | 208 | |
| 7 | 1992 | 192 | |
| 8 | 2011 | 188 | |
| 9 | 2004 | 148 | |
| 10 | 2020 | 136 | |
| 11 | 2011 | 101 | |
| 12 | 1993 | 93 | |
| 13 | 2009 | 91 | |
| 14 | 2008 | 90 | |
| 15 | 1993 | 85 | |
| 16 | 2006 | 75 | |
| 17 | 2012 | 71 | |
| 18 | 2011 | 71 | |
| 19 | 1992 | 69 | |
| 20 | 1997 | 67 |
About Serhat Ünal
Serhat Ünal is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Epidemiology, Molecular Medicine and Clinical Biochemistry, having authored 286 papers that have together received 18.0k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (37 papers), Antibiotic Use and Resistance (31 papers), Bacterial Identification and Susceptibility Testing (29 papers), Antibiotic Resistance in Bacteria (28 papers), SARS-CoV-2 and COVID-19 Research (25 papers), COVID-19 Clinical Research Studies (21 papers), Streptococcal Infections and Treatments (17 papers) and Pneumonia and Respiratory Infections (16 papers). The work is most often cited by research in Infectious Diseases (9.5k citations), Health (2.0k citations), Modeling and Simulation (988 citations), Applied Microbiology and Biotechnology (366 citations) and Molecular Medicine (518 citations). Serhat Ünal has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Adi̇l Deni̇zli̇, Serap Şimşek Yavuz, Ömrüm Uzun, Yeşeren Saylan, Murat Akova, Deniz Gür, Duygu Yazgan Aksoy, Halis Akalın, Lokman Uzun and Özgecan Erdem. Their work appears in journals such as International Journal of Antimicrobial Agents, Clinical Microbiology and Infection, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.